ECM
ENZ

ExodusPoint Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

ExodusPoint Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,166
Closed -$42K – 2753
2021
Q2 		$42K Buy
+13,166
New +$41.4K ﹤0.01% 2238

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ExodusPoint Capital Management's ENZ Position: Q3 2021 in Review

ExodusPoint Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2021, closing a stake of 13,166 shares — an estimated $42K sold.

ExodusPoint Capital Management first reported a position in ENZ in Q2 2021 and held it in 1 quarter. The position peaked at $42K in Q2 2021. 65 funds tracked by Wall St. Rank hold ENZ as of Q3 2021.

  • ExodusPoint Capital Management reported no remaining Enzo Biochem, Inc. position as of Q3 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 13,166 Enzo Biochem, Inc. shares in Q3 2021, an estimated $42K.
  • ExodusPoint Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2021 and held it in 1 quarter.
  • ExodusPoint Capital Management's Enzo Biochem, Inc. position peaked at $42K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.